Introduction to PRES

Posterior Reversible Encephalopathy Syndrome (PRES) is a distinct clinicoradiological entity characterized by acute neurological symptoms and characteristic imaging findings of vasogenic edema, predominantly affecting the posterior regions of the brain. The term "reversible" is key, indicating that with prompt recognition and appropriate management, most patients experience a complete or near-complete recovery of their neurological function and resolution of imaging abnormalities. However, delayed diagnosis or inadequate treatment can lead to irreversible neurological damage.

Causes and Risk Factors

PRES is not a disease in itself but rather a syndrome associated with various underlying conditions that disrupt cerebral autoregulation. The most common trigger for PRES is acute severe hypertension, where a rapid and significant rise in blood pressure overwhelms the brain's ability to regulate cerebral blood flow. Other significant risk factors include:

• Eclampsia and Pre-eclampsia: Pregnancy-related hypertensive disorders are a frequent cause.
• Immunosuppressive Drugs: Medications like calcineurin inhibitors (e.g., tacrolimus, cyclosporine) often used in transplant patients.
• Chemotherapy Agents: Certain anticancer drugs.
• Autoimmune Diseases: Such as systemic lupus erythematosus (SLE) or vasculitis.
• Sepsis and severe infections.
• Renal failure.

Pathophysiology: The Mechanism Behind PRES

The prevailing theory for the pathophysiology of PRES involves a breakdown in cerebral autoregulation. Normally, cerebral blood vessels constrict or dilate to maintain a constant blood flow despite fluctuations in systemic blood pressure. In conditions like severe hypertension, this autoregulatory capacity is exceeded, leading to hyperperfusion of the brain. This increased pressure causes endothelial dysfunction and disruption of the blood-brain barrier, resulting in leakage of plasma proteins and fluid into the brain parenchyma. This accumulation of fluid, known as vasogenic edema, is characteristic of PRES. The posterior circulation, particularly the parieto-occipital lobes, is thought to be more vulnerable due to a less robust sympathetic innervation compared to the anterior circulation, making these areas more susceptible to hyperperfusion and edema.

Clinical Presentation

Patients with PRES typically present with a rapid onset of neurological symptoms. The most common manifestations include:

• Headache: Often severe.
• Seizures: Ranging from focal to generalized tonic-clonic seizures, occurring in a majority of patients.
• Visual Disturbances: These can be quite striking, including blurred vision, hemianopsia, and even cortical blindness.
• Altered Mental Status: Varying from confusion and drowsiness to stupor or coma.
• Focal neurological deficits, though less common, can also occur.

Diagnosis: The Role of MRI

The diagnosis of PRES is primarily clinical, supported by characteristic neuroimaging findings. Magnetic Resonance Imaging (MRI) of the brain is the gold standard for diagnosis. Typical findings on MRI include symmetric or asymmetric areas of high signal intensity on T2-weighted imaging and FLAIR (Fluid-Attenuated Inversion Recovery) sequences. These lesions are predominantly located in the subcortical white matter of the parieto-occipital lobes, though the frontal lobes, temporal lobes, cerebellum, brainstem, and deep grey matter can also be affected. Crucially, these abnormalities are largely reversible with treatment.

Treatment and Prognosis

Treatment for PRES is focused on addressing the underlying cause and managing symptoms. The cornerstone of management involves prompt and controlled reduction of blood pressure, typically using intravenous antihypertensive medications, to prevent further cerebral edema and potential complications. If an offending agent, such as an immunosuppressive drug or chemotherapy, is identified, it should be discontinued or adjusted if clinically feasible.

The prognosis for PRES is generally favorable, with most patients experiencing full neurological recovery and resolution of brain edema on follow-up MRI. However, complications such as hemorrhagic transformation, recurrent PRES, or irreversible neurological deficits (e.g., persistent visual impairment, epilepsy) can occur, especially in cases of delayed diagnosis, severe initial presentation, or inadequate treatment. PRES should be considered a neurological emergency requiring urgent attention.